Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in Scleroderma Lung Study
NCT00004563Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 1999
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cyclophosphamide in systemic sclerosis (SSc), interstitial lung disease (ILD), sponsored by UTHealth Houston. Started Aug 1999; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
systemic sclerosis (SSc)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT00004563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004563.